- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00780936
Effects of a Peripheral Nerve Block on Biomarkers of Pain and Inflammation
November 21, 2008 updated by: Stanford University
Effect of Peripheral Nerve Block on Inflammatory and Nociceptive Biomarkers in a UV-B Burn Model in Humans
The purpose of this study is to determine the effect of a local anesthetic nerve block on markers of inflammation and pain after a sunburn.
This is important because it may provide information regarding the way that nerve blocks help with the treatment of pain and in particular provide preemptive analgesia.
Study Overview
Study Type
Interventional
Enrollment
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:1.
Between 18 and 50 years of age 2. Fluent in English language 3. Provide written informed consent 4. Skin pigmentation type II or III
Exclusion Criteria:1.
Current use of prescription drugs interfering with study objective 2. Use of over-the-counter analgesic/anti-inflammatory drugs within 48h of study participation 3. Current acute or chronic pain conditions 4. Significant medical conditions including psychiatric, neurological, and dermatological diseases 5. Pregnancy 6. Allergies to study drug(s) 7. Concomitant participation in other study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Measurement of the effect of a preemptive peripheral nerve block on the hyperalgesic response to an artificially induced sunburn.
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Measurement of the effect of a preemptive peripheral nerve block on the release of pro-inflammatory cytokines.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Study Completion
July 1, 2008
Study Registration Dates
First Submitted
October 24, 2008
First Submitted That Met QC Criteria
October 27, 2008
First Posted (Estimate)
October 28, 2008
Study Record Updates
Last Update Posted (Estimate)
November 24, 2008
Last Update Submitted That Met QC Criteria
November 21, 2008
Last Verified
November 1, 2008
More Information
Terms related to this study
Other Study ID Numbers
- SU-01222008-984
- eProtocol number 10740
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.